Home > Press > Science and Society - Next Show
Science and Society - Next Show
Dr. David Lemberg
Host - Science and Society
San Diego, CA | August 16, 2005
Dr. David Lemberg, Executive Producer of "Science and Society" - http://www.scienceandsociety.net - announces the show schedule for Wednesday, 8/24/05, 1PM to 2PM Pacific.
Of particular interest to Nanotechnology Now readers is the interview with:
- Dr. Billy J. Stanbery.
While at the University of Washington, Dr. Stanbery was a Research Assistant for Professor Martin Gouterman's Laboratory of Porphyrin Electro-Optics, where he devised experimental strategies and designed experimental equipment for the study of the optical and electronic properties of thin-film photovoltaics fabricated from organic dye compounds.
In 2001, Dr. Stanbery founded HelioVolt Corporation in order to develop and market new technology for applying thin-film photovoltaic coatings to conventional construction materials. He invented the company’s proprietary FASST™ process, a low-cost, flexible manufacturing process for CIGS synthesis. FASST™ is protected by both eight issued U.S. patents and global patents pending.
####
"Science and Society" is a public service of The Hopkins Capital Group www.hopkinscap.com
Media Contact:
David Lemberg
davidlemberg@earthlink.net
Copyright ©
Science and Society
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026
New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026